Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
408 Leser
Artikel bewerten:
(2)

Circle Cardiovascular Imaging Inc.: Unlock Practice Growth: Experience cvi42 at RSNA 2025

See Why Leading Radiologists Are Upgrading to cvi42 This November - Visit Circle at RSNA Booth #7961

Highlights

  • The latest release of cvi42 v6.4 focuses on workflow efficiency and leveraging artificial intelligence
  • In-house post-processing speeds reporting time and captures more reimbursement
  • Circle's vascular capabilities expand with the addition of cvi42 | Vascular CT
  • New business models increase the flexibility and accessibility for reporting physicians

CALGARY, Alberta, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Circle Cardiovascular Imaging (Circle CVI), the market leader in cardiovascular imaging post-processing will unveil its latest release at the Radiological Society of North America (RSNA) Annual General Meeting being held November 30 - December 4 in Chicago, IL. Circle CVI will demonstrate its newest release, cvi42 v6.4.

Radiology leaders know that efficiency, accuracy, and practice growth are non-negotiable. At RSNA 2025, Circle Cardiovascular Imaging invites you to experience the new cvi42 release - a solution engineered to grow your CCT and CMR business.

What cvi42 can do for your practice:

  • Reduce Reporting Times:
    Native integration with PowerScribe automates transcription, minimizing error risk and freeing clinical teams to focus on interpretation rather than manual data entry.
  • Accelerate Patient Care:
    In-house plaque analysis with cvi42 enables faster turnaround times, supporting timely diagnosis and allowing you to deliver a higher standard of care.
  • Drive Confidence and Adoption:
    cvi42 | Vascular CT follows best practices with automated contouring, lowering barriers to using advanced CT vascular analysis - so teams adopt new capabilities faster.
  • Increase Revenue Capture:
    With cvi42 | Plaque you pay for what you process at a fraction of the price of outsourcing and increase your throughput with a streamlined workflow.
  • Elevate Value and Flexibility:
    Our new subscription model provides scalable access to CMR and CCT functionalities ensuring your team has unlimited access to work from anywhere.

"With our latest cvi42 release, we're helping practices unlock greater efficiency, deliver faster patient care, and build a scalable foundation for the future of cardiovascular imaging while supporting business growth" said Chris Bazinet, Chief Revenue Officer of Circle CVI. "We are excited to see how our customers respond to the latest innovations and hear from them how we are solving their challenges"

Benefits for Radiology Leaders and Decision Makers:

  • Minimized risk of error in reporting
  • Improved workflow efficiency, leading to reduced burnout
  • Faster reporting speeds, translating to greater practice performance
  • Flexibility to scale and capture new revenue streams
  • Technology that aligns with evolving best practices and reimbursement guidelines

Join Us at RSNA 2025 - Shape the Future of Cardiovascular Imaging
Nov. 30 - Dec. 3 | Booth #7961, North Hall
Secure your demo now - see how cvi42 can help you lead with confidence and results.

[Save me a spot!]


Enquiries

Circle Marketing
marketing@circlecvi.com

ABOUT CIRCLE CARDIOVASCULAR IMAGING
Circle Cardiovascular Imaging Inc. (Circle CVI) is a Canadian-based company founded in 2007 with a mission to develop innovative software solutions that enhance cardiovascular and cerebrovascular imaging analysis and ultimately improve patient care. Circle's flagship platform, cvi42, delivers best-in-class image reading and reporting tools for quantitative and qualitative assessment of cardiac MR, cardiac CT, vascular CT, and neuro CT.

At the core of Circle's work is a relentless commitment to empowering healthcare providers with advanced, intuitive tools that lead to better healthcare outcomes. This passion for innovation, rooted in both medicine and technology, drives Circle's global impact and fuels a culture of excellence.

Today, millions of medical imaging exams each year-across 1,700+ hospitals in over 90 countries-are interpreted using Circle's cvi42 platform.
For more information, please visit www.circlecvi.com or contact: marketing@circlecvi.com


© 2025 GlobeNewswire (Europe)
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.